X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (42571) 42571
Newsletter (542) 542
Book Chapter (366) 366
Newspaper Article (341) 341
Magazine Article (217) 217
Dissertation (99) 99
Conference Proceeding (50) 50
Publication (34) 34
Book / eBook (28) 28
Reference (16) 16
Web Resource (14) 14
Book Review (3) 3
Journal / eJournal (3) 3
Government Document (2) 2
Transcript (2) 2
Data Set (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28707) 28707
science & technology (25282) 25282
life sciences & biomedicine (24865) 24865
angiotensin-converting enzyme inhibitors - therapeutic use (18493) 18493
male (18240) 18240
female (13808) 13808
animals (11050) 11050
middle aged (10116) 10116
cardiovascular system & cardiology (8924) 8924
angiotensin-converting enzyme inhibitors - pharmacology (8730) 8730
aged (8523) 8523
hypertension - drug therapy (8123) 8123
adult (6532) 6532
cardiac & cardiovascular systems (5723) 5723
blood pressure - drug effects (5676) 5676
hypertension (5637) 5637
rats (5618) 5618
angiotensin (5496) 5496
angiotensin-converting enzyme inhibitors (5098) 5098
angiotensin converting enzyme (4991) 4991
abridged index medicus (4846) 4846
pharmacology & pharmacy (4733) 4733
antihypertensive agents - therapeutic use (4592) 4592
heart failure - drug therapy (4142) 4142
angiotensin-converting enzyme inhibitors - adverse effects (4085) 4085
peripheral vascular disease (4004) 4004
risk factors (3920) 3920
treatment outcome (3894) 3894
adrenergic beta-antagonists - therapeutic use (3827) 3827
angiotensin-converting enzyme inhibitors - administration & dosage (3694) 3694
drug therapy, combination (3534) 3534
general & internal medicine (3280) 3280
renin-angiotensin system - drug effects (3173) 3173
ace inhibitors (3127) 3127
medicine, general & internal (3089) 3089
hypertension - physiopathology (3082) 3082
heart failure (3034) 3034
enzymes (2930) 2930
blood pressure (2814) 2814
angiotensin-converting enzyme (2725) 2725
calcium channel blockers - therapeutic use (2533) 2533
time factors (2522) 2522
diuretics - therapeutic use (2252) 2252
urology & nephrology (2206) 2206
aged, 80 and over (2195) 2195
peptidyl-dipeptidase a - metabolism (2152) 2152
hypertension - complications (2109) 2109
captopril - pharmacology (2104) 2104
angiotensin receptor antagonists (2085) 2085
research (2013) 2013
angiotensin ii type 1 receptor blockers - therapeutic use (1963) 1963
renin-angiotensin system (1946) 1946
double-blind method (1920) 1920
peptidyl-dipeptidase a - genetics (1886) 1886
drug therapy (1882) 1882
dose-response relationship, drug (1777) 1777
angiotensin ii (1752) 1752
enalapril - therapeutic use (1741) 1741
follow-up studies (1728) 1728
heart failure - physiopathology (1682) 1682
analysis (1677) 1677
antihypertensive agents - pharmacology (1666) 1666
retrospective studies (1641) 1641
renin-angiotensin system - physiology (1638) 1638
care and treatment (1615) 1615
prospective studies (1572) 1572
health aspects (1519) 1519
randomized controlled trials as topic (1518) 1518
clinical trials as topic (1511) 1511
captopril (1505) 1505
diabetes (1495) 1495
captopril - therapeutic use (1491) 1491
enzyme inhibitors (1466) 1466
hemodynamics - drug effects (1446) 1446
angiotensin receptor antagonists - therapeutic use (1433) 1433
mortality (1433) 1433
prognosis (1418) 1418
angiotensin-converting enzyme inhibitor (1368) 1368
myocardial infarction - drug therapy (1352) 1352
kidney - drug effects (1346) 1346
angiotensin converting enzyme inhibitors (1338) 1338
physiological aspects (1337) 1337
rats, sprague-dawley (1330) 1330
medicine & public health (1328) 1328
adolescent (1317) 1317
enalapril - pharmacology (1316) 1316
rats, wistar (1284) 1284
physiology (1274) 1274
renin - blood (1245) 1245
rats, inbred shr (1229) 1229
diuretics (1212) 1212
peptidyl-dipeptidase a (1199) 1199
enalapril (1178) 1178
chronic disease (1160) 1160
disease progression (1160) 1160
biochemistry & molecular biology (1142) 1142
antihypertensive agents - administration & dosage (1124) 1124
heart rate - drug effects (1102) 1102
cardiovascular disease (1089) 1089
disease models, animal (1078) 1078
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40236) 40236
Japanese (1096) 1096
German (1031) 1031
French (722) 722
Russian (704) 704
Spanish (431) 431
Italian (268) 268
Chinese (259) 259
Portuguese (229) 229
Polish (223) 223
Korean (97) 97
Czech (87) 87
Danish (86) 86
Hungarian (83) 83
Dutch (73) 73
Swedish (63) 63
Norwegian (57) 57
Finnish (30) 30
Slovak (29) 29
Turkish (29) 29
Romanian (27) 27
Hebrew (22) 22
Ukrainian (22) 22
Serbian (18) 18
Croatian (15) 15
Lithuanian (14) 14
Persian (10) 10
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (4) 4
Belarusian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2016, Volume 374, Issue 16, pp. 1521 - 1532
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2014, Volume 371, Issue 11, pp. 993 - 1004
The angiotensin receptor–neprilysin inhibitor LCZ696 was compared with the ACE inhibitor enalapril in patients with advanced heart failure. LCZ696 was superior... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Heart Failure - drug therapy | Stroke Volume | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Neprilysin - antagonists & inhibitors | Female | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Heart Failure - mortality | Heart failure | Enalapril | Patient outcomes | Angiotensin | Enalaprilat | Dosage and administration | Research | Drug therapy | Enzymes | Statistical analysis | Mortality | Angioedema | Hypotension | Cough | Studies | Hyperkalemia | Death | Neprilysin | Heart diseases | Index Medicus | Abridged Index Medicus | MORTALITY | SURVIVAL | RANDOMIZED-TRIAL | RECEPTOR | Klinisk medicin | NEUTRAL ENDOPEPTIDASE INHIBITION | NATRIURETIC-PEPTIDE | Medicine | Clinical Medicine | CONVERTING ENZYME-INHIBITION | MORBIDITY | EJECTION FRACTION | General & Internal | DOUBLE-BLIND
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2008, Volume 359, Issue 12, pp. 1225 - 1237
In a multicenter trial, 20,332 patients who had recently had an ischemic stroke were randomly assigned to receive either telmisartan or placebo. All patients... 
MORTALITY | HIGH-RISK PATIENTS | DESIGN | RAMIPRIL | RATIONALE | DOUBLE-BLIND | VASCULAR EVENTS | COMBINATION | UMCG Approved | BLOOD-PRESSURE | RANDOMIZED TRIAL | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzoates - adverse effects | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Secondary Prevention | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Treatment Failure | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Heart Failure - epidemiology | Benzimidazoles - therapeutic use | Stroke - prevention & control | Kaplan-Meier Estimate | Stroke - drug therapy | Diabetes Mellitus - epidemiology | Creatinine - blood | Potassium - blood | Aged | Myocardial Infarction - prevention & control | Stroke (Disease) | Prevention | Usage | Health aspects | Telmisartan | Medical research | Stroke | Blood pressure | Index Medicus | Abridged Index Medicus | Blood Pressure | Creatinine | Recurrence | Benzimidazoles | Cardiovascular Diseases | Benzoates | Diabetes Mellitus | Geriatry and gerontology | Life Sciences | Human health and pathology | Myocardial Infarction | Angiotensin-Converting Enzyme Inhibitors | Heart Failure | Potassium | Cardiology and cardiovascular system | Original | Benzimidazoles/adverse effects/therapeutic use | Diabetes Mellitus/epidemiology | Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use | Recurrence/prevention & control | Stroke/drug therapy/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Creatinine/blood | Potassium/blood | Blood Pressure/drug effects | Cardiovascular Diseases/epidemiology/mortality/prevention & control | Benzoates/adverse effects/therapeutic use | Myocardial Infarction/epidemiology/prevention & control | Kaplan-Meiers Estimate | MEDICAL AND HEALTH SCIENCES | Heart Failure/epidemiology/prevention & control
Journal Article